DiaMedica Therapeutics (DMAC) Institutional Ownership $5.80 +0.09 (+1.58%) As of 04:00 PM Eastern Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for DiaMedica Therapeutics (NASDAQ:DMAC)CurrentInstitutional OwnershipPercentage10.12%Number ofInstitutional Buyers(last 12 months)7TotalInstitutional Inflows(last 12 months)$1.31MNumber ofInstitutional Sellers(last 12 months)0 Get DMAC Insider Trade Alerts Want to know when executives and insiders are buying or selling DiaMedica Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data DMAC Institutional Buying and Selling by Quarter DiaMedica Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/16/2024Geode Capital Management LLC306,958$1.29M0.0%+29.6%0.718% 11/15/2024Point72 Asia Singapore Pte. Ltd.9,498$40K0.0%N/A0.022% 10/18/2024Blue Trust Inc.44,247$185K0.0%N/A0.104% 8/16/2024Magnolia Capital Advisors LLC29,500$87K0.0%N/A0.069% 5/10/2024Vanguard Group Inc.1,013,522$2.81M0.0%+26.3%2.670% 2/15/2024Paragon Associates & Paragon Associates II Joint Venture500,000$1.42M3.3%+6.4%1.318% 2/7/2024Avantax Advisory Services Inc.12,500$36K0.0%N/A0.033% 11/15/2023Stonebridge Capital Advisors LLC20,000$52K0.0%N/A0.053% 11/13/2023EAM Investors LLC212,512$548K0.1%-21.4%0.560% 11/9/2023Bleichroeder LP222,317$574K0.1%-24.4%0.586% Get the Latest News and Ratings for DMAC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for DiaMedica Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/1/2023Jacob Asset Management of New York LLC168,730$435K0.6%-15.1%0.445% 8/30/2023Cooperman Leon G875,993$3.78M0.2%+0.9%2.308% 8/10/2023Jacob Asset Management of New York LLC198,730$859K1.0%-15.0%0.738% 8/2/2023Catalyst Financial Partners LLC36,267$157K0.1%+44.4%0.135% 4/11/2023Catalyst Financial Partners LLC25,110$38K0.0%+73.5%0.095% 5/12/2022Jacob Asset Management of New York LLC265,000$663K0.4%-3.6%1.002% 2/15/2022Stonepine Capital Management LLC1,194,670$4.46M2.0%+620.7%4.519% 11/15/2021Marshall Wace LLP10,031$40K0.0%-93.6%0.053% 11/15/2021Manatuck Hill Partners LLC273,100$1.10M0.4%-52.1%1.454% 11/12/2021Stonepine Capital Management LLC165,775$665K0.3%-60.5%0.882% 11/12/2021Jump Financial LLC18,300$73K0.0%N/A0.097% 11/9/2021BlackRock Inc.55,970$225K0.0%-8.6%0.298% 8/25/2021Marshall Wace LLP155,662$693K0.0%+104.9%0.829% 8/16/2021State Street Corp30,217$134K0.0%N/A0.161% 8/16/2021Corriente Advisors LLC203,641$906K0.5%-76.6%1.084% 8/16/2021Marshall Wace LLP155,662$693K0.0%+104.9%0.829% 8/13/2021Renaissance Technologies LLC94,100$419K0.0%-38.5%0.501% 8/13/2021Geode Capital Management LLC133,569$594K0.0%+4.0%0.711% 8/13/2021Vanguard Group Inc.786,266$3.50M0.0%-7.1%4.185% 8/12/2021Trexquant Investment LP17,019$76K0.0%N/A0.091% 8/12/2021Dimensional Fund Advisors LP14,074$63K0.0%N/A0.075% 8/12/2021JPMorgan Chase & Co.8,299$37K0.0%N/A0.044% 8/12/2021Bank of Montreal Can142,846$694K0.0%+36.7%0.760% 5/21/2021Citadel Advisors LLC20,601$189K0.0%N/A0.110% 5/19/2021Squarepoint Ops LLC35,536$325K0.0%N/A0.189% 5/18/2021Millennium Management LLC70,281$643K0.0%+72.0%0.374% 5/18/2021Point72 Asset Management L.P.552,250$5.05M0.0%-31.0%2.940% 5/18/2021Corriente Advisors LLC870,228$7.96M2.9%+7.8%4.632% 5/18/2021Citadel Advisors LLC20,601$189K0.0%N/A0.110% 5/13/2021Barclays PLC3,412$31K0.0%N/A0.018% Do this Before Elon’s Reveal on January 29th (Ad)Elon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but designed to power a $9 trillion AI revolution. And I’ve identified a little-known supplier Elon is depending on to make it all happen.I urge you to watch this video now. 5/13/2021Renaissance Technologies LLC153,100$1.40M0.0%+35.0%0.815% 5/13/2021Bank of New York Mellon Corp40,576$371K0.0%-5.4%0.216% 5/13/2021Bank of Montreal Can104,524$982K0.0%+27.7%0.556% 5/12/2021Northern Trust Corp85,026$778K0.0%-29.7%0.453% 5/12/2021Geode Capital Management LLC128,468$1.18M0.0%+23.9%0.684% 5/12/2021Granite Point Capital Management L.P.184,380$1.69M0.1%-66.3%0.981% 5/11/2021EAM Investors LLC108,232$990K0.1%-1.6%0.576% 5/7/2021BlackRock Inc.60,165$551K0.0%+7.9%0.320% 4/27/2021Dorsey Wright & Associates3,937$36K0.4%N/A0.021% 2/24/2021Virtu Financial LLC15,712$159K0.0%N/A0.084% 2/17/2021Jane Street Group LLC12,537$127K0.0%N/A0.067% 2/16/2021ExodusPoint Capital Management LP13,160$133K0.0%N/A0.070% 2/12/2021Stonepine Capital Management LLC950,000$9.63M7.4%-17.1%5.070% 2/11/2021Northern Trust Corp120,989$1.23M0.0%+3.6%0.646% 2/11/2021Valeo Financial Advisors LLC5,000$51K0.0%N/A0.027% 2/10/2021Renaissance Technologies LLC113,400$1.15M0.0%+18.1%0.605% 2/9/2021Bank of New York Mellon Corp42,905$435K0.0%+218.5%0.229% 2/6/2021Granite Point Capital Management L.P.546,855$5.55M0.3%-15.5%2.918% 2/5/2021BlackRock Inc.55,781$566K0.0%+27.4%0.298% 11/13/2020Morgan Stanley9,100$38K0.0%+56.9%0.049% (Data available from 1/1/2016 forward) DMAC Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of DMAC shares? During the previous two years, 13 institutional investors and hedge funds held shares of DiaMedica Therapeutics. The most heavily invested institutionals were Cooperman Leon G ($3.78M), Vanguard Group Inc. ($2.81M), Paragon Associates & Paragon Associates II Joint Venture ($1.42M), Geode Capital Management LLC ($1.29M), Bleichroeder LP ($574K), EAM Investors LLC ($548K), and Jacob Asset Management of New York LLC ($435K).Learn more on DMAC's institutional investors. What percentage of DiaMedica Therapeutics stock is owned by institutional investors? 10.12% of DiaMedica Therapeutics stock is owned by institutional investors. Learn more on DMAC's institutional investor holdings. Which institutional investors have been buying DiaMedica Therapeutics stock? Of the 10 institutional investors that purchased DiaMedica Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Vanguard Group Inc. ($211.35K), Geode Capital Management LLC ($70.07K), Blue Trust Inc. ($44.25K), Paragon Associates & Paragon Associates II Joint Venture ($30K), Magnolia Capital Advisors LLC ($29.50K), Catalyst Financial Partners LLC ($21.79K), and Stonebridge Capital Advisors LLC ($20K). How much institutional buying is happening at DiaMedica Therapeutics? Institutional investors have bought a total of 456,538 shares in the last 24 months. This purchase volume represents approximately $1.48M in transactions. Which DiaMedica Therapeutics major shareholders have been selling company stock? The following institutional investors have sold DiaMedica Therapeutics stock in the last 24 months: Bleichroeder LP ($71.80K), Jacob Asset Management of New York LLC ($65K), and EAM Investors LLC ($57.91K). How much institutional selling is happening at DiaMedica Therapeutics? Institutional investors have sold a total of 194,707 shares in the last 24 months. This volume of shares sold represents approximately $563.24K in transactions. Related Companies ArriVent BioPharma Major Shareholders Phibro Animal Health Major Shareholders Relay Therapeutics Major Shareholders Cogent Biosciences Major Shareholders Avid Bioservices Major Shareholders Sana Biotechnology Major Shareholders Avadel Pharmaceuticals Major Shareholders Tyra Biosciences Major Shareholders Cronos Group Major Shareholders Immatics Major Shareholders This page (NASDAQ:DMAC) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DiaMedica Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share DiaMedica Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free DMAC Stock Alerts